Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership.

Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, Mosgaard BJ, Nordin A, Rosen B, Engholm G, Gjerstorff ML, Hatcher J, Johannesen TB, McGahan CE, Meechan D, Middleton R, Tracey E, Turner D, Richards MA, Rachet B; ICBP Module 1 Working Group.

Gynecol Oncol. 2012 Oct;127(1):75-82. doi: 10.1016/j.ygyno.2012.06.033. Epub 2012 Jun 27.

PMID:
22750127
[PubMed - indexed for MEDLINE]
2.

Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007.

Maringe C, Walters S, Rachet B, Butler J, Fields T, Finan P, Maxwell R, Nedrebø B, Påhlman L, Sjövall A, Spigelman A, Engholm G, Gavin A, Gjerstorff ML, Hatcher J, Johannesen TB, Morris E, McGahan CE, Tracey E, Turner D, Richards MA, Coleman MP; ICBP Module 1 Working Group.

Acta Oncol. 2013 Jun;52(5):919-32. doi: 10.3109/0284186X.2013.764008. Epub 2013 Apr 15.

PMID:
23581611
[PubMed - indexed for MEDLINE]
3.

Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.

Walters S, Maringe C, Butler J, Rachet B, Barrett-Lee P, Bergh J, Boyages J, Christiansen P, Lee M, Wärnberg F, Allemani C, Engholm G, Fornander T, Gjerstorff ML, Johannesen TB, Lawrence G, McGahan CE, Middleton R, Steward J, Tracey E, Turner D, Richards MA, Coleman MP; ICBP Module 1 Working Group.

Br J Cancer. 2013 Mar 19;108(5):1195-208. doi: 10.1038/bjc.2013.6. Epub 2013 Feb 28.

PMID:
23449362
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007.

Walters S, Maringe C, Coleman MP, Peake MD, Butler J, Young N, Bergström S, Hanna L, Jakobsen E, Kölbeck K, Sundstrøm S, Engholm G, Gavin A, Gjerstorff ML, Hatcher J, Johannesen TB, Linklater KM, McGahan CE, Steward J, Tracey E, Turner D, Richards MA, Rachet B; ICBP Module 1 Working Group.

Thorax. 2013 Jun;68(6):551-64. doi: 10.1136/thoraxjnl-2012-202297. Epub 2013 Feb 11.

PMID:
23399908
[PubMed - indexed for MEDLINE]
5.

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.

Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA; ICBP Module 1 Working Group.

Lancet. 2011 Jan 8;377(9760):127-38. doi: 10.1016/S0140-6736(10)62231-3. Epub 2010 Dec 21.

PMID:
21183212
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership.

Walters S, Maringe C, Butler J, Brierley JD, Rachet B, Coleman MP.

Int J Cancer. 2013 Feb 1;132(3):676-85. doi: 10.1002/ijc.27651. Epub 2012 Jun 28.

PMID:
22623157
[PubMed - indexed for MEDLINE]
7.

Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?

Forbes LJ, Simon AE, Warburton F, Boniface D, Brain KE, Dessaix A, Donnelly C, Haynes K, Hvidberg L, Lagerlund M, Lockwood G, Tishelman C, Vedsted P, Vigmostad MN, Ramirez AJ, Wardle J; International Cancer Benchmarking Partnership Module 2 Working Group.

Br J Cancer. 2013 Feb 5;108(2):292-300. doi: 10.1038/bjc.2012.542. Epub 2013 Jan 31.

PMID:
23370208
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.

Hannibal CG, Cortes R, Engholm G, Kjaer SK.

Acta Obstet Gynecol Scand. 2008;87(12):1353-60. doi: 10.1080/00016340802483000.

PMID:
18951210
[PubMed - indexed for MEDLINE]
9.

Reducing time to diagnosis does not improve outcomes for women with symptomatic ovarian cancer: a report from the Australian Ovarian Cancer Study Group.

Nagle CM, Francis JE, Nelson AE, Zorbas H, Luxford K, de Fazio A, Fereday S, Bowtell DD, Green AC, Webb PM.

J Clin Oncol. 2011 Jun 1;29(16):2253-8. doi: 10.1200/JCO.2010.32.2164. Epub 2011 May 2.

PMID:
21537035
[PubMed - indexed for MEDLINE]
Free Article
10.

The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.

Tetsche MS, Dethlefsen C, Pedersen L, Sorensen HT, Norgaard M.

BMC Cancer. 2008 Jan 29;8:31. doi: 10.1186/1471-2407-8-31.

PMID:
18230177
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?

Chan JK, Loizzi V, Lin YG, Osann K, Brewster WR, DiSaia PJ.

Obstet Gynecol. 2003 Jul;102(1):156-61.

PMID:
12850623
[PubMed - indexed for MEDLINE]
12.

Aspects of survival from colorectal cancer in Denmark.

Iversen LH.

Dan Med J. 2012 Apr;59(4):B4428.

PMID:
22459726
[PubMed - indexed for MEDLINE]
13.

Poorer survival of elderly patients with ovarian cancer: a population-based study.

Petignat P, Fioretta G, Verkooijen HM, Vlastos AT, Rapiti E, Bouchardy C, Vlastos G.

Surg Oncol. 2004 Dec;13(4):181-6.

PMID:
15615654
[PubMed - indexed for MEDLINE]
14.

The effect of centralization of primary surgery on survival in ovarian cancer patients.

Tingulstad S, Skjeldestad FE, Hagen B.

Obstet Gynecol. 2003 Sep;102(3):499-505.

PMID:
12962932
[PubMed - indexed for MEDLINE]
15.

Optimal primary surgical treatment for advanced epithelial ovarian cancer.

Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD007565. doi: 10.1002/14651858.CD007565.pub2. Review.

PMID:
21833960
[PubMed - indexed for MEDLINE]
16.

Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients.

Junor EJ, Hole DJ, McNulty L, Mason M, Young J.

Br J Obstet Gynaecol. 1999 Nov;106(11):1130-6.

PMID:
10549956
[PubMed - indexed for MEDLINE]
17.

Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.

Bačić B, Haller H, Mrklić I, Košta V, Čarić A, Tomić S.

Arch Gynecol Obstet. 2013 Jun;287(6):1219-24. doi: 10.1007/s00404-012-2684-9. Epub 2012 Dec 27.

PMID:
23269354
[PubMed - indexed for MEDLINE]
18.

Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.

Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY.

Gynecol Oncol. 1999 Mar;72(3):278-87.

PMID:
10053096
[PubMed - indexed for MEDLINE]
19.

The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom.

Butler J, Foot C, Bomb M, Hiom S, Coleman M, Bryant H, Vedsted P, Hanson J, Richards M; ICBP Working Group.

Health Policy. 2013 Sep;112(1-2):148-55. doi: 10.1016/j.healthpol.2013.03.021. Epub 2013 May 18.

PMID:
23693117
[PubMed - indexed for MEDLINE]
Free Article
20.

Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study.

O'Malley CD, Cress RD, Campleman SL, Leiserowitz GS.

Gynecol Oncol. 2003 Dec;91(3):608-15.

PMID:
14675685
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk